The Deubiquitinating Enzyme USP14 Promotes the Proliferation and Migration Ability of Pancreatic Cancer Cells
10.13865/j.cnki.cjbmb.2023.06.1672
- Author:
Ying-Ying WANG
1
;
Shuai ZHOU
1
;
Jia-Li ZHANG
1
;
Rong-Hua YU
1
;
Song CHEN
1
;
Song CHEN
2
Author Information
1. Molecular Pathology Center, Academy of Medical Sciences, Zhengzhou University
2. Translational Research Institute, People’ s Hospital of Zhengzhou University
- Publication Type:Journal Article
- Keywords:
cyclin D3 (CCND3);
Key words ubiquitin-specific protease 14 (USP14);
pancreatic cancer;
proliferation
- From:
Chinese Journal of Biochemistry and Molecular Biology
2023;39(8):1113-1121
- CountryChina
- Language:Chinese
-
Abstract:
Pancreatic cancer remains one of the deadliest cancer types with few effective treatment options. While the overexpression of ubiquitin-specific protease 14 (USP14) has been observed in many tumor cells, including pancreatic cancer cells, its precise role in pancreatic cancer is not well defined. Here, we investigated the biological function of USP14 in pancreatic cancer and its molecular mechanisms. Our analysis of the Cancer Genome Atlas database revealed that USP14 was highly expressed in pancreatic cancer tissues,and further investigation revealed that its expression level was negatively correlated with the prognosis of patients. In SW1990 and MIAPaCa2 pancreatic cancer cells,we established stable USP14-knockdown cell lines using the shRNA-USP14 lentivirus and found that USP14 knockdown inhibited the proliferation and migration ability of pancreatic cancer cells by CCK8, colony formation assay, wound-healing and Transwell assays. Western blotting analysis showed that downregulation of USP14 expression resulted in a decrease in CyclinD3 protein levels, while overexpression of USP14 increased the protein levels in SW1990 and MIAPaCa2 pancreatic cancer cells. Furthermore, co-immunoprecipitation demonstrated that USP14 interacts with CyclinD3 and ubiquitination assays show that overexpression of USP14 reduces the ubiquitination level of CyclinD3. Moreover, CRISPR / Cas9-mediated USP14 knockout in SW1990 pancreatic cancer cells resulted in decreased CyclinD3 protein levels. These findings suggest that USP14 promotes the proliferation and migration ability of pancreatic cancer cells by interacting with CyclinD3, highlighting USP14 as a potential therapeutic target for pancreatic cancer.
